Department of Surgery, National Health Insurance Service Ilsan Hospital, 100 ilsan-ro ilsan-donggu, Goyang-si, Gyeonggi-do, 410-719, South Korea,
World J Surg. 2014 Apr;38(4):872-7. doi: 10.1007/s00268-013-2348-3.
The present study was designed to investigate the necessity of completion thyroidectomy for patients who underwent thyroid lobectomy for low-risk papillary thyroid microcarcinoma (PTMC) that was later pathologically diagnosed as central lymph node (CLN) metastasis.
Between 1986 and 2001, we assessed 551 patients who underwent thyroidectomy with prophylactic ipsilateral central compartment neck dissection, and 409 patients were followed-up completely. Thyroid lobectomy were performed in 281 and 128 patients, respectively. The patients were divided into two groups according to CLN metastasis. Clinicopathological profiles and follow-up details were investigated by retrospective chart review.
The CLN-positive and -negative groups were comprised of 43 (15.2 %) and 238 patients (84.8 %), respectively. The mean ages of the two groups were not significantly different (p > 0.05). The mean tumor size of the CLN-positive group (6.8 mm) was significantly larger than that of the CLN-negative group (5.6 mm; p < 0.05). Microscopic capsular invasion was significantly higher in the CLN-positive group (51.2 vs. 23.9 %; p < 0.05). Overall, 21 patients (7.4 %, 21/281) experienced recurrence. Among these, 2 (4.7 %, 2/43) and 19 (8.0 %, 19/238) were in the CLN-positive and -negative groups, respectively. There was no significant correlation between CLN metastasis and tumor recurrence.
Postoperative recurrence was lower in the CLN-positive group, and there was no significant correlation between CLN metastasis and tumor recurrence. Our results suggest that it is not necessary to perform completion thyroidectomy for PTMC patients who have undergone thyroid lobectomy and who have been pathologically diagnosed with CLN metastasis.
本研究旨在探讨对于低危甲状腺乳头状微小癌(PTMC)患者,行甲状腺腺叶切除术并术后病理证实中央区淋巴结(CLN)转移时,是否有必要行甲状腺全切除术。
1986 年至 2001 年间,我们评估了 551 例行预防性同侧中央区颈清扫术的患者,其中 409 例患者获得了完整随访。分别有 281 例和 128 例患者行甲状腺腺叶切除术。根据 CLN 转移情况,将患者分为两组。通过回顾性病历复查,调查两组的临床病理特征和随访情况。
CLN 阳性组和 CLN 阴性组分别包括 43(15.2%)例和 238(84.8%)例患者。两组患者的平均年龄无显著差异(p>0.05)。CLN 阳性组的平均肿瘤大小(6.8mm)显著大于 CLN 阴性组(5.6mm;p<0.05)。CLN 阳性组的镜下包膜侵犯率明显高于 CLN 阴性组(51.2% vs. 23.9%;p<0.05)。总的来说,21 例(7.4%,21/281)患者出现复发。其中,CLN 阳性组 2 例(4.7%,2/43),CLN 阴性组 19 例(8.0%,19/238)出现复发。CLN 转移与肿瘤复发之间无显著相关性。
CLN 阳性组的术后复发率较低,且 CLN 转移与肿瘤复发之间无显著相关性。我们的研究结果表明,对于行甲状腺腺叶切除术且术后病理证实 CLN 转移的 PTMC 患者,不必行甲状腺全切除术。